Lurasidone manufacturers

Filters

Filters

Filters , active

Country of origin : China
1 products found

lurasidone

Tablets 40 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
EU GMP
Comments
Ref. Latuda. Dossier status: Pilot BE completed. Validation stage
Manufacturer #10844
A pharmaceutical manufacturer operating as an end-to-end CDMO/CMO partner for pharmaceutical products, with vertically integrated capabilities spanning active pharmaceutical ingredients, intermediates, and finished oral solid dosage forms such as tablets and capsules. The company highlights multiple cGMP-inspected manufacturing sites supporting both API and formulation supply, alongside strong in-house development and analytical support for scale-up and commercial production. Its quality system is described as fully GMP-driven across operations, with APIs having undergone EU-GMP inspection/certification and oral solid pharmaceutical products produced under Chinese GMP requirements, reinforced by a mature EHS and compliance culture to ensure reliable global supply.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Lurasidone is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Suppliers of lurasidone market it in the form of oral tablets. Alternatives to it are other antipsychotic medications such as perospirone, risperidone, paliperidone, and iloperidone. The developer and earliest manufacturer of lurasidone medications was Sunovion Pharmaceuticals, which first introduced the drug into the market in 2010 under the trade name Latuda. It has since become approved in Canada and across the EU and has seen widespread use, with over 2 million prescriptions for it being registered annually in the U.S. alone. Lurasidone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified lurasidone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.